APR 12, 2018 09:00 AM PDT

DTC Genomic Testing - A Healthcare System Perspective

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Personalized Medicine Integration Manager, Inova Center for Personalized Health
    Biography
      Amjaad Al-Hussain is the Personalized Medicine Integration Manager at Inova. In her role, Amjaad helps lead product development of genomic services and test integration at the Inova Center for Personalized Health.

      Amjaad has played a critical role in developing and growing MediMap® - Inova's pharmacogenomic testing program and the institution's first, trademarked, commercial product line.

      Since starting her career at Inova in 2010, Amjaad has been on the leading edge of the precision medicine movement. For her, being an advocate for genomic health is integral to achieving the mission of helping people and communities live longer, healthier lives.

      Amjaad holds a Master's degree in Health Systems Administration from Georgetown University. She is certified in Lean Six Sigma, received training from the Institute of Healthcare Improvement and was honored with the Excellence in Health Administration Award from the College of Health and Human Services at George Mason University.

    Abstract:

    Ready or not, direct-to-consumer (DTC) genetic testing is here and it is here to stay. As technologies continue to make genetic testing more affordable and accessible to the masses, more individuals are empowered to learn about their genetic information; with or without a physician’s help. Meanwhile, healthcare systems across the country and the world are recognizing how critical it is to integrate genomic testing into everyday patient care to improve outcomes and the overall patient experience. Great progress has been made in oncology and rare-disease diagnoses where genetic testing has become more mainstream. Although some clinical areas have caught up to using these resources, most providers are far behind offering their patients useful genetic testing options that can significantly improve their care. 
    This presentation focuses on a healthcare system’s perspective of how genetic testing has been introduced within its organization, integrated into various service lines and how a shift to direct-to-consumer testing is challenging existing infrastructure. 


    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    SEP 12, 2017 08:00 AM PDT
    SEP 12, 2017 08:00 AM PDT
    DATE: September 12, 2017TIME: 8:00am PT, 11:00am ETEvery year, millions of dollars are wasted on poorly characterized and performing antibodies.  Key researchers in the antibody co...
    Loading Comments...